The study added to a large existing volume of evidence that has consistently shown a risk-reducing effect of OBS on ovarian cancer, said Karen H. Lu, MD, of Moffitt Cancer Center in Tampa, Florida and ...

Early menarche, late menopause, and long reproductive span increase ovarian cancer risk, particularly in postmenopausal women ...

Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with chemotherapy helped reduce the risk of death in patients with a type of ...

Corcept’s overall survival data “look competitive” with AbbVie’s Elahere and Merck’s blockbuster Keytruda, Truist Securities ...

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a compound derived from the traditional Chinese herb Salvia miltiorrhiza, on ...

Separate facts and misconceptions about ovarian cancer to help better prevent and manage the disease.

Corcept Therapeutics (CORT) stock surges after the company said its Phase 3 ROSELLA study for its ovarian cancer drug ...

Corcept Therapeutics, a pharmaceutical company specialising in cortisol-modulating medications, has announced that its ...

Vijayawada: As many as 38,055 women in Andhra Pradesh lost their lives to breast, cervical, and ovarian cancers between 2021 ...

Bangladesh has made notable progress in public health over the past decades. Maternal mortality has declined, immunisation coverage has expanded, and community-based health delivery has saved millions ...